CytomX Therapeutics logo
CytomX Therapeutics CTMX
$ 1.08 -0.92%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

CytomX Therapeutics Deferred Revenue 2011-2024 | CTMX

Annual Deferred Revenue CytomX Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
132 M 121 M 40.8 M 42.1 M 51.4 M 52.7 M 40.6 M 20.3 M 6.13 M 6.13 M 857 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
132 M 857 K 46.8 M

Quarterly Deferred Revenue CytomX Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
96.1 M 124 M 124 M 124 M 120 M 127 M 121 M 61.3 M - 70 M 69.3 M 73.1 M 72.4 M 76.6 M 74.9 M 74.9 M 74.9 M 74.9 M 51.4 M 51.4 M 51.4 M 51.4 M 52.7 M 52.7 M 51.5 M 47 M 40.6 M 56.9 M 46.8 M 40.6 M 20.3 M 20.3 M 20.3 M 20.3 M 6.13 M 6.13 M 6.13 M 6.13 M 6.13 M 6.13 M - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
127 M 6.13 M 58.2 M